Agenda

24/02/2023

Recent Advances in Genitourinary Malignancies (RAGM-2023) - 24 February 2023

Hybrid Congress - PRBB Auditorium - www.ragm.online (08:30h - 14:00h)

On 24 February 2023 will take place a new edition of "Recent Advances in Genitourinary Malignancies (RAGM-2023)" organized by IMIM, Genesis Care and Clínica Corachan and directed by Dr. Joaquim Bellmunt , Dr. Escarlata López and Dr. Juan Pablo Fusco from Genesis Care.

For more information please click https://www.ragm.online/

Registration is already open and it's free.

How to register?
Access to: https://eira.meetingpharma.com/courses/ragm23
Once you are registered introduce the coupon-code: RAGM2023

The program is as follows:

08:00 - 08:30 Registration

08:30 - 08:35 Welcome and Opening Dr. Joan Albanell & Dr. Escarlata López

08:35 - 08:40 Welcome from Dr. Wally Curran, GenesisCare Global CMO

08:40 - 10:05 Round Table 1: Prostatic Cancer
Moderator: Dr. Escarlata López

08:40 - 08:45 Presentation

08:45 - 09:00 Precision medicine in prostatic cancer
Dr. Neal Shore

09:00 - 09:15 Theragnostics in prostatic cancer
Dr. Nat Lenzo

09:15 - 09:30 New ARTA agents in advanced prostate cancer Dr. José Luis Pérez Gracia

09:30 - 09:45 New era of radiotherapy treatments in radioncology. Dr Vladimir Suárez

09:45 - 10:05 Discussion

10:05 - 10:35 Keynote lecture

Presentation: Dr. Joaquin Bellmunt and Dr. Joaquin Arribas
Responding to the climate emergency: actions we can take. William R. Moomaw

10:35 - 10:45 Coffee break

10:45 - 11:55 Round Table 2: Bladder Cancer
Moderator: Dr. Joaquim Bellmunt

10:45 - 10:50 Presentation

10:50 - 11:05 Ongoing trials in Neoad/Adjuvant therapy in MIBC. Dr. Petros Grivas.

11:05 - 11:20 Maintenance immunotherapy in bladder cancer what the future holds. Dr. Begoña Pérez Valderrama

11:20 - 11:35 Future treatment algorithm on sequencing
therapies. Role of Antibody drug conjugates. Dr. Thomas Powles

11:35 - 11:55 Discussion

11:55 - 13:50 Round Table 3: Kidney Cancer
Moderator: Dr. Juan Pablo Fusco

11:55 - 12:10 Clinical Case - Questions

12:10 - 12:25 Presentation

12:25 - 12:40 Adjuvant immunotherapy in renal cell carcinoma
Dr.Pablo Maroto

12:40 - 12:55 Relevant aspects to select the first line of treatment in metastatic renal cell carcinoma patients
Dr. Cristina Suárez

12:55 - 13:10 Second line treatment in metastatic renal cell
carcinoma patients. Dr. McDermott

13:10 - 13:25 Rol of SBRT in olimotastatic renal cell carcinoma
Dr. Miguel Montijano

13:25 - 13:50 Discussion

13:50 - 14:00 Closing remarks
Dr. Joaquim Bellmunt and Dr. Escarlata López

Download the program

______________________________________________________

Contact
Meeting Pharma, A/A Asun Torres
atorres@meetingpharma.com

Todos los actos